ClinicalTrials.Veeva

Menu

Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Addiction

Treatments

Other: SUSIT Condition
Other: Screening Only (SO) condition

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02893514
1R34DA040830-01 (U.S. NIH Grant/Contract)
16-01074

Details and patient eligibility

About

This study will develop a clinical decision support tool that assists primary care providers in carrying out substance use interventions, and then compare (in Phase 2) two clinical scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention received) and changes in drug use at 3 and 6 months, among primary care patients. Investigators will develop the Clinical Decision Support (CDS) component and then test the full SUSIT approach, using mixed methods to assess its acceptability and adoption, and gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a secondary study site to avoid contaminating the SO condition.

Full description

This study has 3 specific aims:

Aim 1 is to develop clinical decision support that assists primary care providers in carrying out a brief intervention.

Aim 2 is to assess the impact of the SUSIT on dose of substance use brief intervention received by patients.

Aim 3 is to gather preliminary evidence on the efficacy of the SUSIT approach for reducing moderate-risk drug use.

Enrollment

79 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Substance use screening results (collected using the tablet-based screening tool) indicating current moderate risk drug use, based on a substance specific involvement score (SSIS) indicating current (past 3 months) use of at least one drug with a moderate risk level (SSIS 4-26), in the absence of any high-risk drug or alcohol use (SSIS 27+);
  • Presenting for visit with a participating PCP

Exclusion criteria

  • Prior participation in the study (i.e. participation in the SO study phase would preclude participation in the SUSIT phase);
  • Attending a formal addiction treatment program (not including informal treatment such as Alcoholics Anonymous, Narcotics Anonymous), in the past 3 months;
  • Pregnant (based on self-report).

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

79 participants in 2 patient groups, including a placebo group

Screening Only (SO)
Placebo Comparator group
Treatment:
Other: Screening Only (SO) condition
Substance Use Screening and Intervention Tool (SUSIT)
Experimental group
Treatment:
Other: SUSIT Condition

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems